Capital World Investors’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-1,631,547
Closed -$18.5M – 585
2022
Q2
$18.5M Hold
1,631,547
– – ﹤0.01% 466
2022
Q1
$36.4M Hold
1,631,547
– – 0.01% 447
2021
Q4
$71.3M Buy
1,631,547
+431,547
+36% +$17.3M 0.01% 399
2021
Q3
$40M Hold
1,200,000
– – 0.01% 481
2021
Q2
$33M Hold
1,200,000
– – 0.01% 496
2021
Q1
$24.1M Hold
1,200,000
– – ﹤0.01% 505
2020
Q4
$39.6M Buy
1,200,000
+194,954
+19% +$5.19M 0.01% 433
2020
Q3
$18.1M Buy
+1,005,046
New +$18.2M ﹤0.01% 477

Other funds holding INBX

Capital World Investors's INBX Position: Q3 2022 in Review

Capital World Investors sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2022, closing a stake of 1,631,547 shares — an estimated $18.5M sold.

Capital World Investors first reported a position in INBX in Q3 2020 and held it in 8 quarters. The position peaked at $71.3M in Q4 2021. 102 funds tracked by Wall St. Rank hold INBX as of Q3 2022.

  • Capital World Investors reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Capital World Investors sold 1,631,547 Inhibrx, Inc. Common Stock shares in Q3 2022, an estimated $18.5M.
  • Capital World Investors first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • Capital World Investors's Inhibrx, Inc. Common Stock position peaked at $71.3M in Q4 2021.
  • 102 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2022.

Based on Capital World Investors's 13F filing for Q3 2022, filed 14 Nov 2022.